Stay updated on Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.

Latest updates to the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page
- Check4 days agoChange DetectedRevision label on the page updated to v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page template or accompanying content.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA minor update to the ClinicalTrials.gov page revision/version indicator is reflected at the bottom of the page.SummaryDifference0.1%

- Check33 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated to v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.1%

- Check76 days agoChange DetectedPlatform revision updated from v3.4.2 to v3.4.3; no changes to the study details.SummaryDifference0.1%

- Check97 days agoChange DetectedFooter revision tag updated from v3.4.1 to v3.4.2; the previous revision tag was removed.SummaryDifference0.1%

Stay in the know with updates to Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.